BrainsWay to Present at the Raymond James Human Health Innovation Conference
08 juin 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate
07 juin 2021 08h01 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC
02 juin 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, June 02, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor
01 juin 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, June 01, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™
24 mai 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, May 24, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
20 mai 2021 08h00 HE
|
BrainsWay
Strong Revenue Growth of 47% Year-over-Year in Q1 2021 Successfully Executed Initial U.S. Controlled Market Release of Deep TMS for Smoking Addiction Strengthened Balance Sheet Through Successful...
BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
19 mai 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of...
BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021
06 mai 2021 16h01 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, May 06, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment...
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
05 mai 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month
04 mai 2021 09h02 HE
|
BrainsWay
CRESSKILL, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...